missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. VLDLR Antibody (04), Novus Biologicals™
  7. 18626008

VLDLR Antibody (04), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP3-06596-50ul

 View more versions of this product

Product Code. 18626008

  • € 231.00 / 50µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

VLDLR Monoclonal antibody specifically detects VLDLR in Human samples. It is validated for ELISA
TRUSTED_SUSTAINABILITY
Specifications

Specifications

VLDLR
Monoclonal
Unconjugated
0.2 um filtered solution in PBS
Mouse
Protein A purified
RUO
Primary
Human
Purified
ELISA
04
ELISA 1:1000-1:2000
CARMQ1, CHRMQ1, FLJ35024, very low density lipoprotein receptor, very low-density lipoprotein receptor, VLDL receptor, VLDL-R, VLDLRCH
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human VLDLR (Accession#: NP_003374.3; Met 1-Ser 797).
50 μg
Apoptosis, Cholesterol Metabolism, Lipid and Metabolism, Neurodegeneration, Neuronal Cell Markers, Neuroscience
7436
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.